HomeARTICLESEmpowering Netflix Series 'Skin Decision: Before and After' Scores 2021 Emmy Nomination for Its Debut Season

Empowering Netflix Series ‘Skin Decision: Before and After’ Scores 2021 Emmy Nomination for Its Debut Season

On the heels of its debut season, Netflix’s original medical/lifestyle reality show Skin Decision: Before and After has received a 2021 Emmy nomination for “Outstanding Lifestyle Series.” The series takes a unique approach to its genre, as it seeks to bring healing, confidence, and self-empowerment to people who have endured traumatic and life-altering experiences.

Featuring board-certified plastic surgeon Dr. Sheila Nazarian, Skin Decision goes beyond superficial appearances and highlights the beauty within each patient while sharing intimate and emotional stories of real-life people who have suffered everything from confidence-crushing relationships to near-fatal car crashes.

When this project came up, I was so excited to get involved. I really wanted to make a new kind of plastic surgery show. Not a circus. Not demeaning to patients,” Nazarian says. “With this show, we really elevated plastic surgery and aesthetic treatments and showed the very real reasons why people get work done. Also, we showed that looking better can make people feel better and do better.”

Though future plans for the show have yet to be disclosed, Dr. Nazarian has many other accomplishments in sight. In addition to running her private practice in Beverly Hills, she will be expanding into Lake Tahoe soon with Spa26& Nazarian Plastic Surgery. Her non-profit, Nazarian Institute and ThinkBIG!, is growing to include surgical education and techniques for other board-certified plastic surgeons. Her ecommerce site The Skin Spot is ready for its re-launch with the new Skin Quiz, curated medical-grade skincare product offerings, Loyalty Points, and a sampling program. She also intends to continue her activism work to end racism against Jews all around the world.

The full series of Skin Decision: Before and After is available on Netflix. The 2021 Emmy Awards will be broadcast on Sept. 19, 2021, on CBS.

 

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy